Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-004202

Chief Operating Officer gave up 1,578 shares (to pay taxes)

  • Chief Operating Officer acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2025-01-14 Option exercise +2,813 60,352 D
BILINSKY IGOR Chief Operating Officer 2025-01-14 Shares withheld for taxes −1,578 $5.89 $9,294 58,774 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2025-01-14 Option exercise · Restricted Stock Units −2,813 0 D
Loading xslF345X05/tm253469-1_4seq1.xml…